- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 1, 2025 | 4.31M sh |
| Short Term Investments | Q3 2025 · Mar 31, 2025 | $6.57M |
| Short Term Investments | Q3 2025 · Jun 30, 2024 | $6.5M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $11.02M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $10.04M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $32.32M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $31.33M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $6.32M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $9.42M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $7.23M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $10.96M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $30.93M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $32.18M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $42.54M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $43.09M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 4.28M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 4.27M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $208K |
| Operating Cash Flow restated | Q3 2025 · Mar 31, 2024 | $2.52M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.02 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.02 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.19 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $2.35M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $6.33M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $89K |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $305K |
| Net Income | Q3 2025 · Mar 31, 2024 | $70K |
| Net Income | Q3 2025 · Mar 31, 2024 | $807K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $59K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $735K |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $2.7M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $8.08M |